Abstract
A lipid-droplet-specific AIEgen was used to evaluate the inhibitory efficacy of HIF-1-targeting drugs by assessing lipid-droplet levels.
Funding Information
  • National Natural Science Foundation of China (21788102)
  • University Grants Committee (AoE/P-03/08)
  • Research Grants Council, University Grants Committee (16308016, N-HKUST604/14, C2014-15G, C6009-17G, A-HKUST 605/16)
  • Innovation and Technology Commission (ITC-CNERC14SC01, ITS/245/17, ITCPD/17-9)

This publication has 68 references indexed in Scilit: